TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹445 Cr | ₹393 Cr | ₹369 Cr | ₹370 Cr | ₹338 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹445 Cr |
Mar2023 | ₹393 Cr |
Mar2022 | ₹369 Cr |
Mar2021 | ₹370 Cr |
Mar2020 | ₹338 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹445 Cr | 13.14 | |
Mar2023 | ₹393 Cr | 6.60 | |
Mar2022 | ₹369 Cr | -0.24 | |
Mar2021 | ₹370 Cr | 9.25 | |
Mar2020 | ₹338 Cr | - |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,193.2 Cr | 4.3% | -2.7% | 54.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 4.3% |
-2.7% |
54.2% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses